Psychiatric Doubts (Short Report)

Abstract

doubts

Keywords

psychiatric

Share and Cite:

Cocchi, M. , Tonello, L. & Gabrielli, F. (2014). Psychiatric Doubts. Open Journal of Depression, 3, 5-8. doi: 10.4236/ojd.2014.31003.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1] Bowden, C. L. (2001). Strategies to reduce misdiagnosis of bipolar depression. Psychiatrical Services, 52, 51-55. http://dx.doi.org/10.1176/appi.ps.52.1.51
[2] Cocchi, M., Tonello, L., & Rasenick, M. M. (2010). Human depression: A new approach in quantitative psychiatry. Annals of General Psychiatry, 9, 25. http://dx.doi.org/10.1186/1744-859X-9-25
[3] Cocchi, M., & Tonello, L. (2010). Bio molecular considerations in Major Depression and Ischemic Cardiovascular Disease. Central Nervous System Agents in Medicinal Chemistry, 10, 97-107.
http://dx.doi.org/10.2174/187152410791196378
[4] Cocchi, M., Tonello, L., Tsaluchidu, S., & Puri, B. K. (2008). The use of artificial neural networks to study fatty acids in neuropsychiatric disorders. BMC Psychiatry, 8, S3.
http://dx.doi.org/10.1186/1471-244X-8-S1-S3
[5] Coleman, M. (1971). Platelet serotonin in disturbed monkeys and children. Clinical Process of Children’s Hospital, 27, 187-194.
[6] Takahashi, S. (1976). Reduction of blood platelet serotonin levels in manic and depressed patients. Folia Psychiatrica et Neurologica Japonica, 30, 475-486.
[7] Sthal, S. M. (1977). The human platelet. A diagnostic and research tool for the study of biogenic amines in psychiatric and neurologic disorders. Archives of General Psychiatry, 34, 509-516.
http://dx.doi.org/10.1001/archpsyc.1977.01770170019001
[8] Kim, H. L., Plaisant, O., Leboyer, M., Gay, C., Kamal, L., Devynck, M. A., & Meyer, P. (1982). Reduction of platelet serotonin in major depression (endogenous depression). Comptes Rendus de l’Académie des Sciences III, 295, 619-622.
[9] Dreux, C., & Launay, J. M. (1985). Blood platelets: Neuronal model in psychiatric disorders. Encephale, 11, 57-64.
[10] Arora, R. C., & Meltzer, H. Y. (1989). Increased serotonin 2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3HLSD) in the blood platelets of depressed patients. Life Science, 44, 725-734. http://dx.doi.org/10.1016/0024-3205(89)90384-6
[11] Thompson, P. (1999). Platelet and erythrocyte membrane and fluidity changes in alcohol dependent patients undergoing acute withdrawal. Alcohol and Alcoholism, 3, 349-354.
http://dx.doi.org/10.1093/alcalc/34.3.349
[12] Camacho, A., & Dimsdale, J. E. (2000). Platelets and psychiatry: Lessons learned from old and new studies. Psychosomatic Medicine, 62, 326-336.
[13] Plein, H., & Berk, M. (2001). The platelet as a peripheral marker in psychiatric illness. Clinical and Experimental Pharmacology and Physiology, 16, 229-236.
[14] McEwen, B. S. (1999). Stress and hippocampal plasticity. Annual Review of Neuroscience, 22, 105-122. http://dx.doi.org/10.1146/annurev.neuro.22.1.105
[15] Duman, S. R., Malberg, J., Nagakawa, S., & D’Sa, C. (2000). Neuronal plasticity and survival in mood disorder. Biological Psychiatry, 48, 732-739. http://dx.doi.org/10.1016/S0006-3223(00)00935-5
[16] Chaouloff, F. (2000). Serotonin, stress and corticoids. Journal of Psychopharmacology, 14, 139-151.
http://dx.doi.org/10.1177/026988110001400203
[17] Bianchi, M., Heidbreder, C., & Crespi, F. (2003). Cytoskeletal changes in the hippocampus following restraint stress: Role of serotonin and microtubules. Synapse, 49, 188-194.
http://dx.doi.org/10.1002/syn.10230
[18] Heron, D. S., Shinitzky, M., Hershkowitz, M., & Samuel, D. (1980). Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes. Proceedings of the National Academy of Sciences, 77, 7463-7467. http://dx.doi.org/10.1073/pnas.77.12.7463
[19] Lee, R. E. (1985). Membrane engineering to rejuvenate the ageing brain. Canadian Medical Association Journal, 132, 325-327.
[20] Cowburn, R. F., Marcusson, J. O., Eriksson, A., Wiehager, B., & O’Neill, C. (1994). Adenylyl cyclase activity and G-protein subunit levels in postmortem frontal cortex of suicide victims. Brain Research, 633, 297-304. http://dx.doi.org/10.1016/0006-8993(94)91552-0
[21] Pacheco, M. A., Stockmeier, C., Meltzer, H. Y., Overholser, J. C., Dilley, G. E., & Jope, R. S. (1996). Alterations in phosphoinositide signaling and G-protein levels in depressed suicide brain. Brain Research, 723, 37-45. http://dx.doi.org/10.1016/0006-8993(96)00207-7
[22] Dowlatshahi, D., MacQueen, G. M., Wang, J. F., Reiach, J. S., & Young, L. T. (1999). G proteincoupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: Effects of diagnosis, suicide, and treatment at the time of death. Journal of Neurochemistry, 73, 1121-1126.
http://dx.doi.org/10.1046/j.1471-4159.1999.0731121.x
[23] Stewart, R. J., Chen, B., Dowlatshahi, D., MacQueen G. M., & Young, L. T. (2001). Abnormalities in the cAMP signaling pathway in post-mortem brain tissue. Brain Research Bulletin, 55, 625-629.
http://dx.doi.org/10.1016/S0361-9230(01)00524-X
[24] Dwivedi, Y., Rizavi, H. S., Conley, R. R., Roberts, R. C., Tamminga, C. A., & Pandey, G. N. (2002). mRNA and protein expression of selective alpha subunits of G proteins are abnormal in prefrontal cortex of suicide victims. Neuropsychopharmacology, 27, 499-517.
[25] Dwivedi, Y., Rizavi, H. S., Shukla, P. K., Lyons, J., Faludi, G., Palkovits, M., Sarosi, A., Conley, R. R., Roberts, R. C., Tamminga, C. A., & Pandey, G. N. (2004). Protein kinase A in postmortem brain of depressed suicide victims: Altered expression of specific regulatory and catalytic subunits. Biological Psychiatry, 55, 234-243. http://dx.doi.org/10.1016/j.biopsych.2003.11.003
[26] Pandey, G. N., Dwivedi, Y., Ren, X., Rizavi, H. S., Monda, A. C., Shukla, P. K., & Conley, R. R. (2005). Brain region specific alterations in the protein and mRNA levels of protein kinase A subunits in the post-mortem brain of teenage suicide victims. Neuropsychopharmacology, 30, 1548-1556.
http://dx.doi.org/10.1038/sj.npp.1300765
[27] Poulter, M. O., Du, L., Weaver, I. C. G., Palkovits, M., Faludi, G., Merali, Z., Szyf, M., & Anisman, H. (2008). GABAA receptor promoter hypermethylation in suicide brain: Implications for the involvement of epigenetic processes. Biological Psychiatics, 64, 645-652.
http://dx.doi.org/10.1016/j.biopsych.2008.05.028
[28] Quilter, C. L., Gilbert, C. L., Oliver, G. L., Jafer, O., Furlong, R. A., Blott, S. C., Wilson, A. E., Sargent, C. A., Mileham, A., & Affara, N. A. (2008). A model for puerperal psychosis. American Journal of Medical Genetics Part B, 147, 1126-1137. http://dx.doi.org/10.1002/ajmg.b.30734
[29] Donati, R. J., Dwivedi, Y., Roberts, R. C., Conley, R. R., Pandey, G. N., & Rasenick, M. M. (2008). Postmortem brain tissue of depressed suicides reveals increased Gs localization in lipid raft domains where it is less likely to activate adenylyl cyclase. Journal of Neuroscience, 28, 3042-3050.
http://dx.doi.org/10.1523/JNEUROSCI.5713-07.2008
[30] Popova, J. S., Greene, A. K., Wang, J., & Rasenick, M. M. (2002). Phosphatidylinositol 4, 5-bisphosphate modifies tubulin participation in phospholipase Cβ1 signaling. Journal of Neuroscience, 22, 1668-1678.
[31] Hameroff, S. R., & Penrose, R. (1996). Orchestrated reduction of quantum coherence in brain microtubules: A model for consciousness. In S. R. Hameroff, A. Kaszniak, & A. C. Scott (Eds.), Toward a science of consciousness—The first Tucson discussions and debates (pp. 507-540). Cambridge, MA: MIT Press.
[32] Hameroff, S. R. (2010). The “conscious pilot”-dendritic synchrony moves through the brain to mediate consciousness. Journal of Biological Physics, 36, 71-93.
http://dx.doi.org/10.1007/s10867-009-9148-x
[33] Tonello, L., & Cocchi, M. (2010). The cell membrane: Is it a bridge from psychiatry to quantum consciousness? Neuro Quantology, 8, 54-60. http://dx.doi.org/10.14704/nq.2010.8.1.268

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.